Data as of Sep 15
| -0.15 / -1.83%|
The 3 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +24.22% increase from the last price of 8.05.
The current consensus among 3 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.